Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Salresp-I - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Salresp-I

Approved

STANDARD

Salresp-I

Ahlcon Parenterals (India) Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: af0dfe92a26c23ab
Company: Ahlcon Parenterals (India) Ltd.
Type: Standard

Approval Details

Approval Id: af0dfe92a26c23ab
Drug Approval Philippines Name: Salresp-I
Product Name: Salresp-I
Registration Number: DRP-1419
Brand Name: Salresp-I
Generic Name: Salbutamol Sulfate + Ipratropium Bromide
Dosage Form: Solution For Inhalation
Dosage Strength: 2.5 mg/500 mcg per 2.5 mL
Manufacturer: Ahlcon Parenterals (India) Ltd.
Importer: I.E. Medica Inc.
Distributor: I.E. Medica Inc.
Issuance Date: 28 December 2021
Expiry Date: 19 May 2027
Pharmacologic Category: Adrenergic in combination with anticholinergic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

af0dfe92a26c23ab

Type

Standard

Back to Philippines FDA Approvals